Post Oncosurgical Reconstruction

Immediate reconstruction begins at the same surgical session as mastectomy — the breast skin envelope and/or chest wall are reconstructed the same day the cancer is removed. This approach preserves the native skin envelope, produces superior aesthetic results, avoids the psychological impact of waking without a breast, and reduces total number of surgeries. Delayed reconstruction is performed weeks to months or years after mastectomy — it is preferred when post-mastectomy radiation is planned (as radiation significantly affects implant outcomes and flap viability) or when the patient needs time to complete adjuvant chemotherapy, recover, and make an informed reconstruction decision. Your oncological and reconstructive teams collaborate to determine the optimal timing.

Implant-based reconstruction uses a tissue expander followed by a permanent silicone implant, or a single-stage direct-to-implant (DTI) technique. It avoids additional donor-site scarring and has shorter initial recovery but is more susceptible to radiation-induced contracture. Autologous flap reconstruction uses your own living tissue — the DIEP flap (deep inferior epigastric perforator flap from the abdominal wall), TRAM flap, or LD flap (latissimus dorsi from the back) — to recreate a warm, soft, natural-feeling breast that ages naturally and responds better to radiation. While autologous reconstruction involves longer surgery and a donor-site scar, it is the gold standard for patients requiring post-mastectomy radiation or those who have failed implant-based approaches.

Yes. Nipple-areolar complex (NAC) reconstruction is the final step in a staged breast reconstruction process, typically performed 3 to 6 months after the breast mound is fully healed and symmetrized. The nipple projection is recreated using local skin flap techniques (such as the C-V flap or skate flap) from the reconstructed breast surface, which is then tattooed 6 to 8 weeks later with medical-grade pigments to reproduce realistic areolar color, texture, and the subtle shadowing of a natural nipple. 3D nipple tattooing alone (without surgical projection) is also an option for patients seeking a non-surgical finish. Results are remarkably natural in skilled hands.

Radiation therapy progressively induces fibrosis, scar contracture, vascular damage, and reduced tissue elasticity in irradiated fields. When an implant has been placed before radiation, the capsule around the implant frequently contracts aggressively (radiation-induced capsular contracture — Baker Grade III/IV) in 30 to 40% of cases, causing breast hardness, pain, and distortion. When radiation is anticipated, the oncoplastic strategy at Olive typically involves placing a tissue expander at mastectomy (to hold the pocket during radiation), completing radiotherapy, allowing 4 to 6 months for radiation effects to stabilize, then replacing the expander with a final implant covered by an autologous tissue flap — or converting entirely to autologous reconstruction.

Reconstructed breasts require tailored surveillance protocols, but reconstruction does not hide recurrences or make them harder to detect. In implant-based reconstruction, standard annual MRI (not mammography) provides clear imaging around the implant. In autologous reconstruction, the reconstructed breast contains only fat, skin, and blood vessels — no glandular tissue — and locoregional recurrences, if they occur, present on the chest wall skin or axilla, which is monitored by clinical examination and ultrasound. All patients continue their oncologist-directed surveillance regardless of reconstruction type.

Multiple peer-reviewed studies consistently demonstrate that breast reconstruction significantly improves psychological well-being, body image, femininity, sexual confidence, and social functioning after mastectomy compared to mastectomy without reconstruction. Patients who receive reconstruction have significantly lower rates of depression, PTSD symptoms related to body image, and clothing-related anxiety. Importantly, studies show no difference in overall survival or cancer recurrence rates between patients who do and do not undergo reconstruction — dispelling concerns that reconstruction "masks" recurrence or stimulates cancer growth.